![about-butterfly2](http://web.archive.org./web/20161101001404im_/http://www.eyepharma.us/wp-content/uploads/2016/09/about-butterfly2.jpg)
About Eye Pharma
Eye Pharma was founded in 1998 as partner of Alcon Italy for the distribution of ophthalmic surgical products. Currently, Eye Pharma is an important player in the market of ophthalmic surgical products in Italy being the main distributor of Alcon’s ophthalmic products to over 50 eye medical centers.
Since its inception, Eye Pharma has gained invaluable experiences and skills in the diagnostic and surgical sectors and has succeeded in positioning itself in the Italian market of ophthalmic products. These important achievements has motived Eye Pharma in 2006 to design an Eye Pharma product line for the prevention and treatment of some chronic degenerative pathologies whose incidence is increasing and for which a preventive therapy is possible (diabetes, hypertension, glaucoma, macular degeneration, and so on).
Currently, Eye Pharma products are distributed in more than 5,000 drug stores throughout Italy. Thought the years Eye Pharma has built its image around its main strengths: innovation and technology becoming a reference point for ophthalmology, one of the oldest medical and surgical fields.
![about-usoffice about-usoffice](http://web.archive.org./web/20161101001404im_/http://www.eyepharma.us/wp-content/uploads/2016/03/about-usoffice.jpg)
![about-lobby](http://web.archive.org./web/20161101001404im_/http://www.eyepharma.us/wp-content/uploads/2016/03/about-lobby.jpg)
The main goal of Eye Pharma is the well-being of individuals. Eye Pharma has invested in scientific research to develop innovative formulations of natural extracts through advanced technologies. The efficacy of Eye Pharma innovative products in the prevention and in the complication reduction of important pathologies is demonstrated by clinical studies.
Eye Pharma collaborates with some of the largest international research centers like the Bascom Palmer Eye Institute in Miami, the Mount Sinai Eye and Hear Institute in New York. Furthermore, Eye Pharma collaborates with other companies that are leaders in the identification and the development of the active principles with pharmacological actions.